Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Gallagher

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Hospital Progress|August 9, 1980
The inability to judge: the malaise of our timeW M Gallagher
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
p53-oriented cancer therapies: current progressW M Gallagher, R Brown
Journal of Molecular Graphics|February 1, 1996
Structural basis of p21H-ras molecular switch inhibition by a neutralizing antibodyW M Gallagher, G H Grant
Cellular and Molecular Life Sciences : CMLS|October 24, 2007
Molecular links between mammary gland development and breast cancerF Lanigan, D O'Connor, F Martin, et al.
The Journal of Pathology|December 21, 2007
Cancer invasion and metastasis: changing viewsM J Duffy, P M McGowan, W M Gallagher
Oncogene|January 16, 1997
Identification of p53 genetic suppressor elements which confer resistance to cisplatinW M Gallagher, M Cairney, B Schott, et al.
Oncogene|June 25, 1999
MBP1: a novel mutant p53-specific protein partner with oncogenic propertiesW M Gallagher, M Argentini, V Sierra, et al.
Cancer Research|March 15, 1996
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cellsD A Anthoney, A J McIlwrath, W M Gallagher, et al.
Journal of Cellular and Molecular Medicine|February 13, 2008
Applications of SELDI-MS technology in oncologyL C Whelan, K A R Power, D T McDowell, et al.
FEBS Letters|March 7, 2001
Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissuesW M Gallagher, L M Greene, M P Ryan, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Hospital Progress|August 9, 1980
The inability to judge: the malaise of our timeW M Gallagher
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
p53-oriented cancer therapies: current progressW M Gallagher, R Brown
Journal of Molecular Graphics|February 1, 1996
Structural basis of p21H-ras molecular switch inhibition by a neutralizing antibodyW M Gallagher, G H Grant
Cellular and Molecular Life Sciences : CMLS|October 24, 2007
Molecular links between mammary gland development and breast cancerF Lanigan, D O'Connor, F Martin, et al.
The Journal of Pathology|December 21, 2007
Cancer invasion and metastasis: changing viewsM J Duffy, P M McGowan, W M Gallagher
Oncogene|January 16, 1997
Identification of p53 genetic suppressor elements which confer resistance to cisplatinW M Gallagher, M Cairney, B Schott, et al.
Oncogene|June 25, 1999
MBP1: a novel mutant p53-specific protein partner with oncogenic propertiesW M Gallagher, M Argentini, V Sierra, et al.
Cancer Research|March 15, 1996
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cellsD A Anthoney, A J McIlwrath, W M Gallagher, et al.
Journal of Cellular and Molecular Medicine|February 13, 2008
Applications of SELDI-MS technology in oncologyL C Whelan, K A R Power, D T McDowell, et al.
FEBS Letters|March 7, 2001
Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissuesW M Gallagher, L M Greene, M P Ryan, et al.
Pageof 3